{
  "regulations" : [ {
    "sentence_tokens" : [ "It", "binds", "with", "high", "affinity", "to", "the", "VEGF-A", "isoforms", ",", "thus", "preventing", "binding", "of", "VEGF-A", "to", "its", "receptors", "(", "European", "Medicines", "Agency", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 12, 13, 14, 15, 16, 17 ],
    "trigger_indices" : [ 11, 12 ],
    "rule_name" : "Negative_regulation_syntax_1_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "resultant", "hypoxia", "then", "further", "up-regulate", "VEGF", "levels", "again", "(", "Storkebaum", "and", "Carmeliet", ",", "2004", ")", "." ],
    "event_indices" : [ 2, 3, 4, 5, 6, 7, 8 ],
    "type" : "Positive_regulation",
    "polarity" : true,
    "controller_indices" : [ 2, 3 ],
    "controlled_indices" : [ 6, 7, 8 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Positive_regulation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "VEGF", "administration", "inhibits", "DA", "neurons", "loss", "in", "PD", "models", ",", "especially", "in", "the", "substantia", "nigra", "and", "in", "the", "striatum", "(", "Sheikh", "et", "al", ".,", "2017", ")", ",", "thus", "representing", "a", "potential", "therapeutic", "target", "for", "prevention", "of", "DA", "neuron", "death", "and", "PD", "progression", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 3, 4 ],
    "trigger_indices" : [ 2, 3 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "state", "of", "brain", "hypoxia", "up-regulates", "VEGF", "and", "its", "subsequent", "higher", "levels", "mediate", "angiogenesis", ",", "causing", "microvascular", "leakage", "and", "fragility", "." ],
    "event_indices" : [ 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 8, 9, 10, 11, 12 ],
    "controlled_indices" : [ 13, 14 ],
    "trigger_indices" : [ 12, 13 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "It", "has", "been", "postulated", "that", "reduced", "VEGF", "levels", "may", "cause", "neurodegeneration", ",", "by", "impairing", "neural", "tissue", "perfusion", ",", "thus", "causing", "ischemia", "and", "production", "of", "free", "radicals", "(", "Storkebaum", "and", "Carmeliet", ",", "2004", ")", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 6, 7, 8 ],
    "controlled_indices" : [ 20, 21 ],
    "trigger_indices" : [ 9, 10 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "However", ",", "the", "use", "of", "anti-VEGF", "drugs", ",", "which", "are", "on", "the", "market", "since", "2005", ",", "was", "not", "considered", "in", "any", "of", "the", "studies", "and", "it", "cannot", "be", "excluded", "that", "anti-VEGF", "drugs", "rather", "than", "AMD", "itself", "triggered", "the", "clinical", "manifestation", "of", "PD", "." ],
    "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 30, 31 ],
    "controlled_indices" : [ 41, 42 ],
    "trigger_indices" : [ 36, 37 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "However", ",", "the", "use", "of", "anti-VEGF", "drugs", ",", "which", "are", "on", "the", "market", "since", "2005", ",", "was", "not", "considered", "in", "any", "of", "the", "studies", "and", "it", "cannot", "be", "excluded", "that", "anti-VEGF", "drugs", "rather", "than", "AMD", "itself", "triggered", "the", "clinical", "manifestation", "of", "PD", "." ],
    "event_indices" : [ 34, 35, 36, 37, 38, 39, 40, 41, 42 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 34, 35 ],
    "controlled_indices" : [ 41, 42 ],
    "trigger_indices" : [ 36, 37 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "event_indices" : [ 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 12, 13 ],
    "controlled_indices" : [ 19, 20 ],
    "trigger_indices" : [ 9, 10 ],
    "rule_name" : "Negative_activation_syntax_2_noun",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "event_indices" : [ 8, 9, 10, 11, 12, 13 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 12, 13 ],
    "controlled_indices" : [ 8, 9 ],
    "trigger_indices" : [ 9, 10 ],
    "rule_name" : "Negative_activation_syntax_2_noun",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "event_indices" : [ 9, 10, 11, 12, 13, 14, 15 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 12, 13 ],
    "controlled_indices" : [ 14, 15 ],
    "trigger_indices" : [ 9, 10 ],
    "rule_name" : "Negative_activation_syntax_2_noun",
    "rule" : null
  } ],
  "hardInstances" : [ {
    "sentence_tokens" : [ "It", "binds", "with", "high", "affinity", "to", "the", "VEGF-A", "isoforms", ",", "thus", "preventing", "binding", "of", "VEGF-A", "to", "its", "receptors", "(", "European", "Medicines", "Agency", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "VEGF", "administration", "inhibits", "DA", "neurons", "loss", "in", "PD", "models", ",", "especially", "in", "the", "substantia", "nigra", "and", "in", "the", "striatum", "(", "Sheikh", "et", "al", ".,", "2017", ")", ",", "thus", "representing", "a", "potential", "therapeutic", "target", "for", "prevention", "of", "DA", "neuron", "death", "and", "PD", "progression", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 36, 37 ], [ 37, 38, 39 ], [ 40, 41 ] ]
  }, {
    "sentence_tokens" : [ "The", "state", "of", "brain", "hypoxia", "up-regulates", "VEGF", "and", "its", "subsequent", "higher", "levels", "mediate", "angiogenesis", ",", "causing", "microvascular", "leakage", "and", "fragility", "." ],
    "entities_indices" : [ [ 3, 4, 5 ], [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "use", "of", "anti-VEGF", "drugs", ",", "which", "are", "on", "the", "market", "since", "2005", ",", "was", "not", "considered", "in", "any", "of", "the", "studies", "and", "it", "cannot", "be", "excluded", "that", "anti-VEGF", "drugs", "rather", "than", "AMD", "itself", "triggered", "the", "clinical", "manifestation", "of", "PD", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 34, 35 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "use", "of", "anti-VEGF", "drugs", ",", "which", "are", "on", "the", "market", "since", "2005", ",", "was", "not", "considered", "in", "any", "of", "the", "studies", "and", "it", "cannot", "be", "excluded", "that", "anti-VEGF", "drugs", "rather", "than", "AMD", "itself", "triggered", "the", "clinical", "manifestation", "of", "PD", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 30, 31 ] ]
  }, {
    "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 8, 9 ], [ 14, 15 ], [ 24, 25 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 14, 15 ], [ 19, 20 ], [ 24, 25 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 8, 9 ], [ 19, 20 ], [ 24, 25 ], [ 27, 28 ] ]
  } ],
  "withoutRegulations" : [ {
    "sentence_tokens" : [ "Long-Term", "Intravitreal", "Ranibizumab", "as", "a", "Potential", "Additional", "Risk", "Factor", "for", "Neurodegeneration", "in", "Parkinson", "'s", "Disease", ":", "A", "Case", "Report", "." ],
    "entities_indices" : [ [ 7, 8, 9 ], [ 12, 13, 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "In", "May", "2016", ",", "the", "patient", "complained", "of", "left", "hand", "resting", "tremor", ",", "bradykinesia", ",", "and", "postural", "rigidity", "of", "head", "and", "trunk", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Age", "related", "macular", "degeneration", "(", "AMD", ")", "is", "a", "chronic", "progressive", "disorder", "of", "the", "retina", ",", "representing", "the", "main", "cause", "of", "irreversible", "vision", "loss", "in", "elderly", "people", "(", "de", "Jong", ",", "2006", ")", "in", "both", "Western", "and", "Eastern", "Countries.The", "neovascular", "or", "\"", "wet", "\"", "AMD", "is", "characterized", "by", "choroidal", "neovascularization", "and", "vascular", "leakage", ",", "associated", "with", "up-regulation", "of", "angiogenic", "factors", ",", "such", "as", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", ",", "a", "cytokine", "that", "promotes", "vascular", "permeability", "and", "angiogenesis", "." ],
    "entities_indices" : [ [ 0, 1, 2, 3, 4 ], [ 5, 6 ], [ 22, 23 ], [ 44, 45 ], [ 48, 49, 50 ], [ 63, 64, 65, 66, 67 ], [ 68, 69 ], [ 78, 79 ] ]
  }, {
    "sentence_tokens" : [ "Accessed", "01", "Feb", "2018", ")", ",", "following", "monthly", "intravitreal", "injections", "in", "AMD", "patients", ",", "serum", "concentrations", "of", "ranibizumab", "generally", "range", "between", "0.79", "and", "2.90", "ng/ml", "." ],
    "entities_indices" : [ [ 11, 12 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "On", "the", "other", "hand", ",", "there", "is", "a", "strong", "biological", "plausibility", "and", "temporal", "relationship", "between", "intensive", "intravitreal", "administration", "of", "ranibizumab", "and", "onset", "of", "PD", "related", "signs", "and", "symptoms", "which", "may", "suggest", "a", "role", "of", "the", "anti-VEGF", "drug", "as", "additional", "risk", "factor", "resulting", "potentially", "in", "accelerating", "the", "PD", "related", "neurodegeneration", "process.PD", "is", "a", "multi-systemic", "neurodegenerative", "disease", ",", "primarily", "affecting", "DA", "neurons", "of", "substantia", "nigra", ",", "and", "characterized", "by", "intracellular", "accumulation", "of", "the", "protein", "alpha-synuclein", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "entities_indices" : [ [ 23, 24 ], [ 25, 26, 27, 28 ], [ 46, 47 ], [ 53, 54, 55 ], [ 58, 59 ], [ 72, 73 ] ]
  }, {
    "sentence_tokens" : [ "In", "May", "2015", ",", "visual", "acuity", "further", "reduced", "to", "3/10", "and", "both", "fundus", "examination", "and", "OCT", "revealed", "a", "reactivation", "of", "the", "neovascular", "membrane", ",", "edema", "and", "pigment", "epithelial", "detachment", "." ],
    "entities_indices" : [ [ 15, 16 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "We", "described", "the", "development", "of", "PD", "in", "a", "patient", "without", "any", "genetic", "and", "environmental", "risk", "factor", "for", "PD", ",", "who", "received", "repeated", "intravitreal", "injections", "of", "ranibizumab", "for", "wet", "AMD", "over", "the", "previous", "year", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 17, 18 ], [ 25, 26 ], [ 28, 29 ] ]
  }, {
    "sentence_tokens" : [ "Ranibizumab", "maintains", "effective", "retinal", "concentrations", "for", "around", "1", "month", ",", "being", "able", "to", "reach", "low", "concentrations", "in", "the", "serum", "compartment", "as", "well", "(", "Stewart", ",", "2012", ";", "Gibson", "and", "Gibson", ",", "2014", ")", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "Case", "Report", "." ],
    "entities_indices" : [ [ 0, 1, 2 ] ]
  }, {
    "sentence_tokens" : [ "After", "obtaining", "informed", "consent", ",", "the", "patient", "was", "monthly", "treated", "with", "intravitreal", "administration", "of", "0.5", "mg", "ranibizumab", "for", "three", "months", ",", "without", "any", "complication", "and", "with", "complete", "retinal", "hemorrhage", "and", "edema", "resolution", "and", "increased", "visual", "acuity", "of", "left", "eye", "(", "10/10", ")", "." ],
    "entities_indices" : [ [ 27, 28, 29 ], [ 30, 31 ] ]
  }, {
    "sentence_tokens" : [ "The", "most", "liable", "mechanisms", "potentially", "explaining", "the", "relationship", "between", "AMD", "and", "PD", "are", "related", "to", "neurodegenerative", "processes", "and", "chronic", "inflammation", ":", "the", "activation", "of", "microglia", "cells", "in", "the", "retina", "and", "nervous", "system", "may", "trigger", "the", "inflammatory", "response", "and", "aggravate", "both", "the", "retinal", "and", "DA", "degeneration", "(", "Whitton", ",", "2007", ")", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 11, 12 ], [ 19, 20 ], [ 35, 36, 37 ], [ 43, 44 ] ]
  }, {
    "sentence_tokens" : [ "ES", "and", "FM", "critically", "reviewed", "the", "manuscript", "for", "important", "intellectual", "content", "and", "suggested", "valuable", "comments", ",", "which", "improved", "the", "quality", "of", "the", "manuscript", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 2, 3 ] ]
  }, {
    "sentence_tokens" : [ "Such", "concentrations", "are", "below", "the", "drug", "concentration", "necessary", "to", "inhibit", "the", "VEGF", "activity", "by", "50", "%", "(", "IC", "=", "11", "-", "27", "ng/ml", ")", "." ],
    "entities_indices" : [ [ 11, 12 ], [ 17, 18, 19, 20, 21, 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "All", "the", "above", "described", "experimental", "and", "epidemiological", "evidence", "raise", "the", "hypothesis", "that", "persistent", "and", "intensive", "VEGF", "inhibition", "concurred", "to", "DA", "degeneration", "in", "our", "patient", "." ],
    "entities_indices" : [ [ 15, 16 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Clinical", "trials", "on", "ranibizumab", "showed", "a", "high", "incidence", "of", "stroke", ",", "myocardial", "infarction", "and", "non", "ocular", "hemorrhage", "(", "Brown", "et", "al", ".,", "2006", ";", "Rosenfeld", "et", "al", ".,", "2006", ")", ",", "further", "confirmed", "by", "recent", "observational", "studies", "(", "Kemp", "et", "al", ".,", "2013", ";", "Pratt", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 9, 10 ], [ 11, 12, 13 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "In", "November", "2012", ",", "a", "72-year", "old", "patient", "was", "diagnosed", "with", "left", "eye", "wet", "age", "related", "macular", "degeneration", "." ],
    "entities_indices" : [ [ 14, 15, 16, 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "A", "recent", "study", "on", "the", "Italian", "ADR", "Spontaneous", "Reporting", "System", "showed", "3", "reports", "of", "\"", "extrapyramidal", "syndrome", "\"", "due", "to", "intravitreal", "bevacizumab", "and", "1", "to", "intravitreal", "aflibercept", "(", "Cutroneo", "et", "al", ".,", "2017", ")", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "A", "diagnosis", "of", "clinically", "established", "PD", "was", "made", "based", "on", "new", "criteria", "of", "the", "Movement", "Disorders", "Society", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 14, 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "The", "resulting", "systemic", "VEGF", "inhibition", "after", "intravitreal", "injections", "may", "lead", "to", "systemic", "effects", "(", "Gibson", "and", "Gibson", ",", "2014", ")", "." ],
    "entities_indices" : [ [ 3, 4 ] ]
  }, {
    "sentence_tokens" : [ "He", "did", "not", "complain", "non", "motor", "symptoms.Neurological", "examination", "disclosed", "resting", "tremor", "on", "the", "left", "hand", ",", "mild", "bradykinesia", "of", "left", "lower", "limb", ",", "and", "mild", "rigidity", "of", "head", "and", "trunk", "." ],
    "entities_indices" : [ [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "The", "clinical", "picture", "with", "lack", "of", "atypical", "features", "is", "consistent", "with", "the", "clinical", "diagnosis", "of", "PD", "." ],
    "entities_indices" : [ [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "These", "changes", "lead", "to", "edema", ",", "bleeding", ",", "and", "impair", "neural", "tissue", "perfusion", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "Thereafter", ",", "the", "patient", "underwent", "routine", "follow-up", "visits", ",", "on", "a", "2-month", "basis", ",", "including", "fundus", "examination", "and", "OCT", "which", "did", "not", "document", "any", "abnormal", "finding", "." ],
    "entities_indices" : [ [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "A", "treatment", "with", "levodopa", "and", "carbidopa", "(", "300", "mg/daily", ")", "was", "started", "at", "the", "beginning", "of", "2017", ",", "due", "to", "worsening", "of", "tremor", "and", "bradykinesia", "leading", "to", "gait", "impairment", "and", "fatigue", "(", "motor", "UPDRS", "=", "15/108", ")", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 5, 6 ], [ 22, 23 ], [ 30, 31 ] ]
  }, {
    "sentence_tokens" : [ "GT", ",", "IM", ",", "PC", "wrote", "the", "manuscript", "in", "collaboration", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 2, 3 ], [ 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "Functional", "polymorphisms", "of", "the", "VEGF", "gene", "expression", "have", "been", "associated", "with", "an", "increased", "risk", "of", "developing", "PD", "in", "the", "Chinese", "Ham", "population", "(", "Wu", "et", "al", ".,", "2016", ")", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 5, 6, 7 ], [ 16, 17 ], [ 20, 21 ] ]
  }, {
    "sentence_tokens" : [ "She", "has", "received", "honoraria", "for", "speaking", "from", "UCB", "Pharma", ",", "Medtronic", ",", "Chiesi", ",", "Abbvie", ",", "Allergan", ",", "Merz", ",", "and", "Zambon", "." ],
    "entities_indices" : [ [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Finally", ",", "a", "meta-analysis", "of", "randomized", "trials", "on", "ranibizumab", "for", "AMD", "treatment", "identified", "a", "stronger", "relationship", "of", "systemic", "vascular", "adverse", "events", "and", "intravitreal", "administration", "of", "VEGF", "inhibitors", "in", "case", "of", "more", "intensive", "treatment", "schedule", "(", "Ueta", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 25, 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "She", "has", "been", "part", "of", "advisory", "boards", "of", "Medtronic", ",", "Merz", ",", "and", "UCB", "Pharma", "." ],
    "entities_indices" : [ [ 13, 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Inhibition", "of", "the", "neuroprotective", "effects", "associated", "to", "VEGF", "may", "theoretically", "play", "a", "role", "in", "the", "development", "of", "neurodegenerative", "disorders", "involving", "dopamine", "transmission", ",", "including", "PD.We", "report", "a", "case", "of", "PD", "which", "occurred", "after", "long-term", "treatment", "with", "intravitreal", "injections", "of", "ranibizumab", "for", "the", "treatment", "of", "wet", "AMD", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 17, 18, 19 ], [ 20, 21 ], [ 29, 30 ], [ 39, 40 ], [ 45, 46 ] ]
  }, {
    "sentence_tokens" : [ "The", "presence", "of", "vascular", "lesions", "in", "the", "basal", "ganglia", "at", "brain", "MRI", "does", "not", "exclude", "the", "diagnosis", "of", "idiopathic", "PD", ",", "as", "they", "have", "been", "described", "in", "PD", "patients", "with", "vascular", "risk", "factors", ",", "such", "as", "hypertension", "(", "Antonini", "et", "al", ".,", "2012", ")", "." ],
    "entities_indices" : [ [ 11, 12 ], [ 19, 20 ], [ 27, 28 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "Specifically", ",", "ranibizumab", "binds", "to", "the", "VEGF-A", ",", "one", "of", "the", "five", "isoforms", "of", "the", "VEGF", "family", "and", "one", "of", "the", "strongest", "inducers", "of", "vascular", "permeability", "(", "Yla-Herttuala", "et", "al", ".,", "2007", ")", ",", "which", "showed", "neuroprotective", "effects", "in", "several", "in", "vitro", "and", "in", "vivo", "PD", "models", "(", "Silverman", "et", "al", ".,", "1999", ";", "Pitzer", "et", "al", ".,", "2003", ";", "Yasuhara", "et", "al", ".,", "2004", ";", "Tian", "et", "al", ".,", "2007", ";", "Yue", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 6, 7 ], [ 15, 16 ], [ 45, 46 ] ]
  }, {
    "sentence_tokens" : [ "The", "patient", "received", "three", "monthly", "intravitreal", "injections", "of", "ranibizumab", ",", "with", "complete", "resolution", "of", "retinal", "hemorrhage", "and", "edema", "and", "reinstatement", "of", "visual", "acuity", "." ],
    "entities_indices" : [ [ 8, 9 ], [ 14, 15, 16 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "A", "diagnosis", "of", "clinically", "established", "PD", "was", "made", "based", "on", "new", "criteria", "of", "the", "Movement", "Disorders", "Society", "(", "Postuma", "et", "al", ".,", "2015", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 14, 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "At", "follow-up", "examination", "in", "May", "2017", ",", "response", "to", "levodopa", "was", "demonstrated", "by", "improvement", "of", "motor", "symptoms", "(", "motor", "UPDRS", "=", "6/108", ")", ",", "particularly", "of", "gait", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Recent", "studies", "demonstrated", "in", "PD", "patients", "the", "presence", "of", "alpha-synuclein", "in", "the", "retina", "(", "Bodis-Wollner", "et", "al", ".,", "2014", ")", "as", "well", "the", "presence", "of", "specific", "OCT", "abnormalities", ",", "such", "as", "reduced", "parafoveal", "thickness", "(", "Slotnick", "et", "al", ".,", "2015", ")", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 9, 10 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Results", "from", "clinical", "trials", "documented", "no", "significant", "reduction", "in", "serum", "VEGF", "levels", "within", "the", "first", "1", "month", "of", "treatment", "(", "Zehetner", "et", "al", ".,", "2015", ")", ",", "but", "a", "significant", "decline", "in", "systemic", "VEGF", "levels", "was", "detected", "after", "1", "and", "2", "years", "(", "Enders", "et", "al", ".,", "2015", ")", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "In", "the", "same", "period", ",", "the", "patient", "referred", "to", "the", "Movement", "Disorders", "Clinic", "due", "to", "intermittent", "tremor", "on", "the", "left", "hand", ",", "started", "around", "February", "2016", "." ],
    "entities_indices" : [ [ 10, 11, 12 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "This", "effect", "has", "been", "highlighted", "also", "on", "dopaminergic", "(", "DA", ")", "neurons", "and", "on", "both", "in", "vitro", "and", "in", "vivo", "pre-clinical", "studies", "on", "Parkinson", "'", "s", "disease", "(", "PD", ")", "models", "(", "Yasuhara", "et", "al", ".,", "2004", ",", "2005a", ",", "b", ";", "Yasuda", "et", "al", ".,", "2007", ";", "Falk", "et", "al", ".,", "2011", ";", "Piltonen", "et", "al", ".,", "2011", ";", "Yue", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 23, 24, 25, 26, 27 ], [ 28, 29 ], [ 48, 49, 50, 51, 52, 53 ], [ 54, 55, 56, 57, 58, 59 ] ]
  }, {
    "sentence_tokens" : [ "In", "conclusion", ",", "our", "case", "report", "points", "out", "to", "VEGF", "inhibition", "as", "a", "possible", "additional", "risk", "factor", "of", "neurodegeneration", "of", "DA", "neurons", "in", "PD.According", "to", "the", "Naranjo", "causality", "assessment", "scale", "(", "Naranjo", "et", "al", ".,", "1981", ")", ",", "the", "causal", "relationship", "between", "use", "of", "ranibizumab", "and", "PD", "development", "was", "scored", "as", "\"", "possible", "\"", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 20, 21 ], [ 44, 45 ], [ 46, 47 ] ]
  }, {
    "sentence_tokens" : [ "Adjusting", "for", "several", "vascular", "risk", "factors", "(", "i.e", ".,", "coronary", "heart", "disease", ",", "hypertension", ",", "diabetes", ",", "and", "hyperlipidemia", ")", ",", "subjects", "with", "AMD", "had", "a", "significant", "higher", "risk", "of", "developing", "PD", "than", "AMD-free", "patients", "during", "follow-up", "." ],
    "entities_indices" : [ [ 9, 10, 11, 12 ], [ 13, 14 ], [ 18, 19 ], [ 23, 24 ], [ 31, 32 ] ]
  }, {
    "sentence_tokens" : [ "On", "the", "other", "hand", ",", "the", "onset", "of", "such", "disorders", "may", "be", "due", "to", "vascular", "events", "and/or", "stroke", ",", "which", "are", "well", "known", "and", "listed", "risks", "of", "intravitreal", "therapy", "with", "anti-VEGF", "drugs", "in", "general", ",", "including", "ranibizumab", "." ],
    "entities_indices" : [ [ 17, 18 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "Single", "Photon", "Emission", "Computerized", "Tomography", "of", "the", "Dopamine", "Transporter", "with", "(", "123I", ")", "ioflupane", "documented", "a", "low", "Dopamine", "Transporter", "(", "DAT", ")", "uptake", "mostly", "in", "the", "right", "striatum", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 17, 18 ], [ 20, 21 ] ]
  }, {
    "sentence_tokens" : [ "The", "DAT", "SPECT", "evidence", "of", "pre-synaptic", "dopamine", "loss", "supports", "the", "presence", "of", "neurodegeneration", "in", "the", "nigro-striatal", "pathway", ",", "typical", "of", "neurodegenerative", "Parkinsonism", "." ],
    "entities_indices" : [ [ 1, 2 ], [ 6, 7 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "EM", ",", "CT", ",", "and", "FM", "collected", "the", "data", "and", "performed", "the", "investigation", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "Chung", "et", "al.", "(", "2014", ")", "investigated", "the", "risk", "of", "developing", "PD", "within", "3", "years", "after", "the", "AMD", "diagnosis", "in", "a", "retrospective", "cohort", ",", "population", "based", ",", "claims", "database", "study", "in", "Taiwan", "." ],
    "entities_indices" : [ [ 11, 12 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "Up", "to", "November", "2017", "other", "two", "injections", "of", "ranibizumab", "were", "intravitreally", "administered", "with", "visual", "acuity", "equal", "to", "3/10", "and", "the", "patient", "was", "in", "stable", "treatment", "with", "levodopa", "and", "carbidopa", "(", "300", "mg/daily", ")", "." ],
    "entities_indices" : [ [ 8, 9 ], [ 26, 27 ], [ 28, 29 ] ]
  }, {
    "sentence_tokens" : [ "Recent", "evidence", "suggested", "that", "the", "VEGF", "signal", "pathway", "may", "directly", "and", "indirectly", "improve", "DA", "neuron", "survival", "(", "Silverman", "et", "al", ".,", "1999", ";", "Pitzer", "et", "al", ".,", "2003", ";", "Yasuhara", "et", "al", ".,", "2004", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Dilated", "fundus", "examination", "revealed", "a", "subretinal", "whitish", "mass", "and", "adjacent", "subretinal", "hemorrhage", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "FM", "declares", "she", "receives", "royalties", "from", "publication", "of", "the", "book", "\"", "Disorders", "of", "Movement", "\"", "(", "Springer", "2016", ")", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "This", "hypothesis", "is", "consistent", "with", "a", "recent", "autopsy", "study", "in", "patients", "with", "dementia", "with", "Lewy", "body", ",", "in", "whom", "VEGF", "deficiency", "has", "been", "associated", "with", "a", "loss", "of", "microvessels", "and", "low", "occipital", "blood", "flow", "(", "Miners", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 12, 13 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "At", "that", "time", ",", "he", "was", "treated", "with", "combination", "of", "angiotensin", "converting", "enzyme", "inhibitor", "plus", "thiazide", "diuretic", "for", "a", "20-year", "history", "of", "well", "controlled", "hypertension.His", "best", "corrected", "visual", "acuity", "in", "the", "right", "and", "left", "eyes", "was", "10/10", "and", "8/10", ",", "respectively", "." ],
    "entities_indices" : [ [ 10, 11, 12, 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Magnetic", "Resonance", "Imaging", "of", "the", "brain", "showed", "rare", "small", "subcortical", "white", "matters", "hyperintensities", "on", "T2", "(", "mainly", "periventricular", "and", "frontal", ")", "and", "some", "bilateral", "hypointensities", "in", "T1", "in", "the", "striatum", ",", "more", "prominent", "on", "the", "right", ",", "compatible", "with", "small", "ischemic", "lesions.Single", "Photon", "Emission", "Computerized", "Tomography", "(", "SPECT", ")", "of", "the", "Dopamine", "Transporter", "(", "DAT", ")", "with", "123I-ioflupane", "documented", "a", "significant", "and", "clear", "low", "uptake", "of", "DAT", ",", "mostly", "in", "the", "right", "striatum", "(", "Figure", "1", ")", "." ],
    "entities_indices" : [ [ 51, 52 ], [ 54, 55 ], [ 57, 58 ], [ 66, 67 ] ]
  }, {
    "sentence_tokens" : [ "Through", "reduction", "of", "edema", "and", "new", "blood", "vessel", "growth", ",", "VEGF", "inhibitors", "administered", "by", "intravitreal", "injection", "are", "an", "established", "treatment", "for", "\"", "wet", "\"", "AMD", "and", "include", "bevacizumab", "(", "only", "as", "off-label", "use", ")", ",", "pegaptanib", ",", "and", ",", "more", "recently", ",", "ranibizumab", "and", "aflibercept.Recent", "studies", "revealed", "that", "VEGF", "displays", "a", "key", "role", "in", "neuronal", "survival", "and", "proliferation", "(", "Drake", "and", "Little", ",", "1995", ";", "Silverman", "et", "al", ".,", "1999", ";", "Storkebaum", "and", "Carmeliet", ",", "2004", ")", ",", "with", "neuroprotective", "effects", ",", "due", "to", "apoptosis", "inhibition", ",", "stimulation", "of", "neurogenesis", ",", "and", "activation", "of", "antioxidants", "(", "Zachary", ",", "2005", ";", "Krum", "et", "al", ".,", "2008", ";", "Nowacka", "and", "Obuchowicz", ",", "2012", ";", "Quittet", "et", "al", ".,", "2015", ")", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 10, 11, 12 ], [ 24, 25 ], [ 35, 36 ], [ 48, 49 ], [ 57, 58 ], [ 84, 85 ], [ 89, 90 ] ]
  }, {
    "sentence_tokens" : [ "VEGF", "shows", "neuroprotective", "effects", ",", "due", "to", "apoptosis", "inhibition", ",", "stimulation", "of", "neurogenesis", ",", "and", "activation", "of", "antioxidants", "(", "Zachary", ",", "2005", ";", "Krum", "et", "al", ".,", "2008", ";", "Nowacka", "and", "Obuchowicz", ",", "2012", ";", "Quittet", "et", "al", ".,", "2015", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 7, 8 ], [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "In", "particular", ",", "we", "hypothesize", "that", "long-term", "treatment", "with", "intravitreal", "ranibizumab", "led", "to", "a", "persistent", "inhibition", "of", "VEGF", "activity", "which", "played", "an", "important", "compensatory", "neuroprotective", "role", "in", "older", "patient", "with", "AMD", ",", "ultimately", "triggering", "PD", "." ],
    "entities_indices" : [ [ 17, 18 ], [ 30, 31 ], [ 34, 35 ] ]
  }, {
    "sentence_tokens" : [ "Moreover", ",", "brain", "MRI", "did", "not", "disclose", "areas", "of", "cortical", "and", "subcortical", "atrophy", ",", "suggesting", "the", "diagnosis", "of", "atypical", "Parkinsonism", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 12, 13 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "The", "patient", "was", "periodically", "followed-up", "but", "not", "treated", "with", "anti-VEGF", "drugs", "as", "there", "was", "no", "sign", "of", "neovascularization", "." ],
    "entities_indices" : [ [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "Due", "to", "the", "documented", "protective", "role", "of", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "on", "the", "dopaminergic", "neurons", ",", "intensive", "intravitreal", "injections", "of", "the", "anti-VEGF", "agent", "ranibizumab", "may", "have", "played", "as", "an", "additional", "risk", "factor", "accelerating", "the", "neurodegeneration", "process", "related", "to", "PD", "and", "the", "onset", "of", "the", "related", "clinical", "signs", "and", "symptoms", "." ],
    "entities_indices" : [ [ 7, 8, 9, 10, 11 ], [ 12, 13 ], [ 24, 25, 26, 27 ], [ 41, 42 ], [ 49, 50, 51, 52 ] ]
  }, {
    "sentence_tokens" : [ "Similarly", ",", "in", "the", "Food", "and", "Drug", "Administration", "'", "s", "Adverse", "Event", "Reporting", "System", ",", "three", "cases", "of", "neurodegenerative", "disorders", "have", "been", "reported", "following", "bevacizumab", "use", "(", "Shamloo", "et", "al", ".,", "2012", ")", "." ],
    "entities_indices" : [ [ 18, 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Serum", "ranibizumab", "concentrations", "are", "predicted", "to", "be", "approximately", "90,000-fold", "lower", "than", "vitreal", "ranibizumab", "concentrations", "." ],
    "entities_indices" : [ [ 1, 2 ] ]
  }, {
    "sentence_tokens" : [ "On", "the", "contrary", ",", "a", "case-control", "study", "found", "no", "statistically", "significant", "differences", "in", "the", "frequency", "of", "AMD", "between", "patients", "with", "idiopathic", "PD", "and", "healthy", "subjects", "(", "Nowacka", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 16, 17 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "The", "patient", "had", "no", "family", "history", "of", "PD", "or", "other", "neurodegenerative", "diseases", "nor", "had", "he", "been", "ever", "exposed", "to", "pesticides", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 10, 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "OCT", "confirmed", "the", "presence", "of", "a", "subretinal", "lesion", "and", "intraretinal", "edema", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "AMD", "may", "be", "considered", "as", "a", "neurodegeneration", "of", "the", "retina", "(", "de", "Jong", ",", "2006", ")", ",", "thus", "potentially", "sharing", "with", "PD", "common", "biological", "pathways", ",", "such", "as", "oxidative", "stress", "and", "inflammation", "(", "Ding", "et", "al", ".,", "2009", ";", "Poewe", "et", "al", ".,", "2017", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 21, 22 ], [ 31, 32 ], [ 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "Ranibizumab", "is", "a", "humanized", "recombinant", "monoclonal", "antibody", "fragment", "targeted", "against", "human", "VEGF", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "In", "November", "2012", ",", "a", "72-year", "old", "man", "was", "diagnosed", "with", "wet", "AMD", "in", "his", "left", "eye", ",", "based", "on", "fundus", "examination", "and", "optical", "coherence", "tomography", "(", "OCT", ")", ",", "which", "was", "requested", "for", "the", "onset", "of", "metamorphopsia", "." ],
    "entities_indices" : [ [ 12, 13 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "On", "the", "other", "hand", ",", "VEGF", "is", "up-regulated", "by", "ischemic", "and", "inflammatory", "stimulation", ",", "which", "accompany", "neurodegeneration", "." ],
    "entities_indices" : [ [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "Furthermore", ",", "a", "meta-analysis", "of", "randomized", "trials", "on", "ranibizumab", "for", "AMD", "treatment", "identified", "a", "stronger", "relationship", "of", "systemic", "vascular", "adverse", "events", "and", "intravitreal", "administration", "of", "VEGF", "inhibitors", "in", "case", "of", "more", "intensive", "treatment", "schedule", "(", "Ueta", "et", "al", ".,", "2014", ")", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 25, 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Using", "claims", "databases", "from", "the", "United", "States", ",", "Brilliant", "et", "al.", "(", "2016", ")", "found", "that", "around", "70", "%", "of", "the", "levodopa", "users", "started", "the", "drug", "treatment", "after", "AMD", "diagnosis", "." ],
    "entities_indices" : [ [ 21, 22 ], [ 28, 29 ] ]
  } ],
  "emptySentences" : [ {
    "sentence_tokens" : [ "Long-Term", "Intravitreal", "Ranibizumab", "as", "a", "Potential", "Additional", "Risk", "Factor", "for", "Neurodegeneration", "in", "Parkinson", "'s", "Disease", ":", "A", "Case", "Report", "." ]
  }, {
    "sentence_tokens" : [ "In", "November", "2012", ",", "a", "72-year", "old", "patient", "was", "diagnosed", "with", "left", "eye", "wet", "age", "related", "macular", "degeneration", "." ]
  }, {
    "sentence_tokens" : [ "The", "patient", "received", "three", "monthly", "intravitreal", "injections", "of", "ranibizumab", ",", "with", "complete", "resolution", "of", "retinal", "hemorrhage", "and", "edema", "and", "reinstatement", "of", "visual", "acuity", "." ]
  }, {
    "sentence_tokens" : [ "In", "May", "2015", ",", "symptomatic", "relapse", "was", "detected", "." ]
  }, {
    "sentence_tokens" : [ "The", "patient", "was", "again", "treated", "with", "intravitreal", "ranibizumab", ",", "with", "overall", "six", "injections", "till", "the", "end", "of", "February", "2016", "." ]
  }, {
    "sentence_tokens" : [ "In", "May", "2016", ",", "the", "patient", "complained", "of", "left", "hand", "resting", "tremor", ",", "bradykinesia", ",", "and", "postural", "rigidity", "of", "head", "and", "trunk", "." ]
  }, {
    "sentence_tokens" : [ "A", "diagnosis", "of", "clinically", "established", "PD", "was", "made", "based", "on", "new", "criteria", "of", "the", "Movement", "Disorders", "Society", "." ]
  }, {
    "sentence_tokens" : [ "Single", "Photon", "Emission", "Computerized", "Tomography", "of", "the", "Dopamine", "Transporter", "with", "(", "123I", ")", "ioflupane", "documented", "a", "low", "Dopamine", "Transporter", "(", "DAT", ")", "uptake", "mostly", "in", "the", "right", "striatum", "." ]
  }, {
    "sentence_tokens" : [ "Due", "to", "the", "documented", "protective", "role", "of", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", "on", "the", "dopaminergic", "neurons", ",", "intensive", "intravitreal", "injections", "of", "the", "anti-VEGF", "agent", "ranibizumab", "may", "have", "played", "as", "an", "additional", "risk", "factor", "accelerating", "the", "neurodegeneration", "process", "related", "to", "PD", "and", "the", "onset", "of", "the", "related", "clinical", "signs", "and", "symptoms", "." ]
  }, {
    "sentence_tokens" : [ "Introduction", "." ]
  }, {
    "sentence_tokens" : [ "Age", "related", "macular", "degeneration", "(", "AMD", ")", "is", "a", "chronic", "progressive", "disorder", "of", "the", "retina", ",", "representing", "the", "main", "cause", "of", "irreversible", "vision", "loss", "in", "elderly", "people", "(", "de", "Jong", ",", "2006", ")", "in", "both", "Western", "and", "Eastern", "Countries.The", "neovascular", "or", "\"", "wet", "\"", "AMD", "is", "characterized", "by", "choroidal", "neovascularization", "and", "vascular", "leakage", ",", "associated", "with", "up-regulation", "of", "angiogenic", "factors", ",", "such", "as", "vascular", "endothelial", "growth", "factor", "(", "VEGF", ")", ",", "a", "cytokine", "that", "promotes", "vascular", "permeability", "and", "angiogenesis", "." ]
  }, {
    "sentence_tokens" : [ "Through", "reduction", "of", "edema", "and", "new", "blood", "vessel", "growth", ",", "VEGF", "inhibitors", "administered", "by", "intravitreal", "injection", "are", "an", "established", "treatment", "for", "\"", "wet", "\"", "AMD", "and", "include", "bevacizumab", "(", "only", "as", "off-label", "use", ")", ",", "pegaptanib", ",", "and", ",", "more", "recently", ",", "ranibizumab", "and", "aflibercept.Recent", "studies", "revealed", "that", "VEGF", "displays", "a", "key", "role", "in", "neuronal", "survival", "and", "proliferation", "(", "Drake", "and", "Little", ",", "1995", ";", "Silverman", "et", "al", ".,", "1999", ";", "Storkebaum", "and", "Carmeliet", ",", "2004", ")", ",", "with", "neuroprotective", "effects", ",", "due", "to", "apoptosis", "inhibition", ",", "stimulation", "of", "neurogenesis", ",", "and", "activation", "of", "antioxidants", "(", "Zachary", ",", "2005", ";", "Krum", "et", "al", ".,", "2008", ";", "Nowacka", "and", "Obuchowicz", ",", "2012", ";", "Quittet", "et", "al", ".,", "2015", ")", "." ]
  }, {
    "sentence_tokens" : [ "This", "effect", "has", "been", "highlighted", "also", "on", "dopaminergic", "(", "DA", ")", "neurons", "and", "on", "both", "in", "vitro", "and", "in", "vivo", "pre-clinical", "studies", "on", "Parkinson", "'", "s", "disease", "(", "PD", ")", "models", "(", "Yasuhara", "et", "al", ".,", "2004", ",", "2005a", ",", "b", ";", "Yasuda", "et", "al", ".,", "2007", ";", "Falk", "et", "al", ".,", "2011", ";", "Piltonen", "et", "al", ".,", "2011", ";", "Yue", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "Inhibition", "of", "the", "neuroprotective", "effects", "associated", "to", "VEGF", "may", "theoretically", "play", "a", "role", "in", "the", "development", "of", "neurodegenerative", "disorders", "involving", "dopamine", "transmission", ",", "including", "PD.We", "report", "a", "case", "of", "PD", "which", "occurred", "after", "long-term", "treatment", "with", "intravitreal", "injections", "of", "ranibizumab", "for", "the", "treatment", "of", "wet", "AMD", "." ]
  }, {
    "sentence_tokens" : [ "Case", "Report", "." ]
  }, {
    "sentence_tokens" : [ "In", "November", "2012", ",", "a", "72-year", "old", "man", "was", "diagnosed", "with", "wet", "AMD", "in", "his", "left", "eye", ",", "based", "on", "fundus", "examination", "and", "optical", "coherence", "tomography", "(", "OCT", ")", ",", "which", "was", "requested", "for", "the", "onset", "of", "metamorphopsia", "." ]
  }, {
    "sentence_tokens" : [ "At", "that", "time", ",", "he", "was", "treated", "with", "combination", "of", "angiotensin", "converting", "enzyme", "inhibitor", "plus", "thiazide", "diuretic", "for", "a", "20-year", "history", "of", "well", "controlled", "hypertension.His", "best", "corrected", "visual", "acuity", "in", "the", "right", "and", "left", "eyes", "was", "10/10", "and", "8/10", ",", "respectively", "." ]
  }, {
    "sentence_tokens" : [ "On", "slit-lamp", "examination", ",", "both", "anterior", "chambers", "showed", "clear", "aqueous", "humor", "and", "no", "inflammatory", "reaction", "." ]
  }, {
    "sentence_tokens" : [ "Dilated", "fundus", "examination", "revealed", "a", "subretinal", "whitish", "mass", "and", "adjacent", "subretinal", "hemorrhage", "." ]
  }, {
    "sentence_tokens" : [ "OCT", "confirmed", "the", "presence", "of", "a", "subretinal", "lesion", "and", "intraretinal", "edema", "." ]
  }, {
    "sentence_tokens" : [ "After", "obtaining", "informed", "consent", ",", "the", "patient", "was", "monthly", "treated", "with", "intravitreal", "administration", "of", "0.5", "mg", "ranibizumab", "for", "three", "months", ",", "without", "any", "complication", "and", "with", "complete", "retinal", "hemorrhage", "and", "edema", "resolution", "and", "increased", "visual", "acuity", "of", "left", "eye", "(", "10/10", ")", "." ]
  }, {
    "sentence_tokens" : [ "Thereafter", ",", "the", "patient", "underwent", "routine", "follow-up", "visits", ",", "on", "a", "2-month", "basis", ",", "including", "fundus", "examination", "and", "OCT", "which", "did", "not", "document", "any", "abnormal", "finding", "." ]
  }, {
    "sentence_tokens" : [ "In", "May", "2014", ",", "a", "reduction", "of", "visual", "acuity", "(", "from", "10/10", "to", "7/10", ")", "was", "registered", "." ]
  }, {
    "sentence_tokens" : [ "The", "patient", "was", "periodically", "followed-up", "but", "not", "treated", "with", "anti-VEGF", "drugs", "as", "there", "was", "no", "sign", "of", "neovascularization", "." ]
  }, {
    "sentence_tokens" : [ "In", "May", "2015", ",", "visual", "acuity", "further", "reduced", "to", "3/10", "and", "both", "fundus", "examination", "and", "OCT", "revealed", "a", "reactivation", "of", "the", "neovascular", "membrane", ",", "edema", "and", "pigment", "epithelial", "detachment", "." ]
  }, {
    "sentence_tokens" : [ "For", "this", "reason", ",", "the", "patient", "was", "again", "treated", "with", "intravitreal", "injections", "of", "ranibizumab", "(", "0.5", "mg", ")", ",", "firstly", "on", "a", "monthly", "basis", "and", "thereafter", "using", "treat", "and", "extend", "approach", ",", "with", "overall", "six", "injections", "till", "the", "end", "of", "February", "2016", ",", "when", "visual", "acuity", "increased", "to", "6/10", "." ]
  }, {
    "sentence_tokens" : [ "At", "the", "follow-up", "visit", "in", "May", "2016", ",", "the", "neovascular", "membrane", "appeared", "inactive", "and", "the", "visual", "acuity", "was", "stable", "at", "6/10", ",", "so", "the", "ophthalmologist", "decided", "for", "a", "pro", "re", "nata", "approach", "(", "i.e", ".,", "as", "needed", ")", "." ]
  }, {
    "sentence_tokens" : [ "In", "the", "same", "period", ",", "the", "patient", "referred", "to", "the", "Movement", "Disorders", "Clinic", "due", "to", "intermittent", "tremor", "on", "the", "left", "hand", ",", "started", "around", "February", "2016", "." ]
  }, {
    "sentence_tokens" : [ "He", "did", "not", "complain", "non", "motor", "symptoms.Neurological", "examination", "disclosed", "resting", "tremor", "on", "the", "left", "hand", ",", "mild", "bradykinesia", "of", "left", "lower", "limb", ",", "and", "mild", "rigidity", "of", "head", "and", "trunk", "." ]
  }, {
    "sentence_tokens" : [ "His", "motor", "Unified", "Parkinson", "'", "s", "Disease", "Rating", "Scale", "(", "UPDRS", ")", "was", "11/108", "." ]
  }, {
    "sentence_tokens" : [ "The", "patient", "had", "no", "family", "history", "of", "PD", "or", "other", "neurodegenerative", "diseases", "nor", "had", "he", "been", "ever", "exposed", "to", "pesticides", "." ]
  }, {
    "sentence_tokens" : [ "Magnetic", "Resonance", "Imaging", "of", "the", "brain", "showed", "rare", "small", "subcortical", "white", "matters", "hyperintensities", "on", "T2", "(", "mainly", "periventricular", "and", "frontal", ")", "and", "some", "bilateral", "hypointensities", "in", "T1", "in", "the", "striatum", ",", "more", "prominent", "on", "the", "right", ",", "compatible", "with", "small", "ischemic", "lesions.Single", "Photon", "Emission", "Computerized", "Tomography", "(", "SPECT", ")", "of", "the", "Dopamine", "Transporter", "(", "DAT", ")", "with", "123I-ioflupane", "documented", "a", "significant", "and", "clear", "low", "uptake", "of", "DAT", ",", "mostly", "in", "the", "right", "striatum", "(", "Figure", "1", ")", "." ]
  }, {
    "sentence_tokens" : [ "A", "diagnosis", "of", "clinically", "established", "PD", "was", "made", "based", "on", "new", "criteria", "of", "the", "Movement", "Disorders", "Society", "(", "Postuma", "et", "al", ".,", "2015", ")", "." ]
  }, {
    "sentence_tokens" : [ "A", "treatment", "with", "levodopa", "and", "carbidopa", "(", "300", "mg/daily", ")", "was", "started", "at", "the", "beginning", "of", "2017", ",", "due", "to", "worsening", "of", "tremor", "and", "bradykinesia", "leading", "to", "gait", "impairment", "and", "fatigue", "(", "motor", "UPDRS", "=", "15/108", ")", "." ]
  }, {
    "sentence_tokens" : [ "At", "follow-up", "examination", "in", "May", "2017", ",", "response", "to", "levodopa", "was", "demonstrated", "by", "improvement", "of", "motor", "symptoms", "(", "motor", "UPDRS", "=", "6/108", ")", ",", "particularly", "of", "gait", "." ]
  }, {
    "sentence_tokens" : [ "Up", "to", "November", "2017", "other", "two", "injections", "of", "ranibizumab", "were", "intravitreally", "administered", "with", "visual", "acuity", "equal", "to", "3/10", "and", "the", "patient", "was", "in", "stable", "treatment", "with", "levodopa", "and", "carbidopa", "(", "300", "mg/daily", ")", "." ]
  }, {
    "sentence_tokens" : [ "Discussion", "." ]
  }, {
    "sentence_tokens" : [ "We", "described", "the", "development", "of", "PD", "in", "a", "patient", "without", "any", "genetic", "and", "environmental", "risk", "factor", "for", "PD", ",", "who", "received", "repeated", "intravitreal", "injections", "of", "ranibizumab", "for", "wet", "AMD", "over", "the", "previous", "year", "." ]
  }, {
    "sentence_tokens" : [ "The", "clinical", "picture", "with", "lack", "of", "atypical", "features", "is", "consistent", "with", "the", "clinical", "diagnosis", "of", "PD", "." ]
  }, {
    "sentence_tokens" : [ "The", "DAT", "SPECT", "evidence", "of", "pre-synaptic", "dopamine", "loss", "supports", "the", "presence", "of", "neurodegeneration", "in", "the", "nigro-striatal", "pathway", ",", "typical", "of", "neurodegenerative", "Parkinsonism", "." ]
  }, {
    "sentence_tokens" : [ "Moreover", ",", "brain", "MRI", "did", "not", "disclose", "areas", "of", "cortical", "and", "subcortical", "atrophy", ",", "suggesting", "the", "diagnosis", "of", "atypical", "Parkinsonism", "." ]
  }, {
    "sentence_tokens" : [ "The", "presence", "of", "vascular", "lesions", "in", "the", "basal", "ganglia", "at", "brain", "MRI", "does", "not", "exclude", "the", "diagnosis", "of", "idiopathic", "PD", ",", "as", "they", "have", "been", "described", "in", "PD", "patients", "with", "vascular", "risk", "factors", ",", "such", "as", "hypertension", "(", "Antonini", "et", "al", ".,", "2012", ")", "." ]
  }, {
    "sentence_tokens" : [ "On", "the", "other", "hand", ",", "there", "is", "a", "strong", "biological", "plausibility", "and", "temporal", "relationship", "between", "intensive", "intravitreal", "administration", "of", "ranibizumab", "and", "onset", "of", "PD", "related", "signs", "and", "symptoms", "which", "may", "suggest", "a", "role", "of", "the", "anti-VEGF", "drug", "as", "additional", "risk", "factor", "resulting", "potentially", "in", "accelerating", "the", "PD", "related", "neurodegeneration", "process.PD", "is", "a", "multi-systemic", "neurodegenerative", "disease", ",", "primarily", "affecting", "DA", "neurons", "of", "substantia", "nigra", ",", "and", "characterized", "by", "intracellular", "accumulation", "of", "the", "protein", "alpha-synuclein", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ]
  }, {
    "sentence_tokens" : [ "Recent", "studies", "demonstrated", "in", "PD", "patients", "the", "presence", "of", "alpha-synuclein", "in", "the", "retina", "(", "Bodis-Wollner", "et", "al", ".,", "2014", ")", "as", "well", "the", "presence", "of", "specific", "OCT", "abnormalities", ",", "such", "as", "reduced", "parafoveal", "thickness", "(", "Slotnick", "et", "al", ".,", "2015", ")", "." ]
  }, {
    "sentence_tokens" : [ "The", "retina", "has", "several", "molecular", "and", "cellular", "features", "in", "common", "with", "the", "brain", ",", "such", "as", "neurons", ",", "glial", "cells", ",", "connected", "vasculature", ",", "and", "a", "blood", "barrier", "(", "Trost", "et", "al", ".,", "2016", ")", "." ]
  }, {
    "sentence_tokens" : [ "The", "most", "liable", "mechanisms", "potentially", "explaining", "the", "relationship", "between", "AMD", "and", "PD", "are", "related", "to", "neurodegenerative", "processes", "and", "chronic", "inflammation", ":", "the", "activation", "of", "microglia", "cells", "in", "the", "retina", "and", "nervous", "system", "may", "trigger", "the", "inflammatory", "response", "and", "aggravate", "both", "the", "retinal", "and", "DA", "degeneration", "(", "Whitton", ",", "2007", ")", "." ]
  }, {
    "sentence_tokens" : [ "Ranibizumab", "is", "a", "humanized", "recombinant", "monoclonal", "antibody", "fragment", "targeted", "against", "human", "VEGF", "." ]
  }, {
    "sentence_tokens" : [ "Lucentis", "-", "Summary", "of", "Product", "Characteristics", "." ]
  }, {
    "sentence_tokens" : [ "Available", "from", ":", "http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf", "." ]
  }, {
    "sentence_tokens" : [ "Accessed", "01", "Feb", "2018", ")", "." ]
  }, {
    "sentence_tokens" : [ "Ranibizumab", "maintains", "effective", "retinal", "concentrations", "for", "around", "1", "month", ",", "being", "able", "to", "reach", "low", "concentrations", "in", "the", "serum", "compartment", "as", "well", "(", "Stewart", ",", "2012", ";", "Gibson", "and", "Gibson", ",", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "Based", "on", "the", "Summary", "of", "Product", "Characteristics", "(", "European", "Medicines", "Agency", "." ]
  }, {
    "sentence_tokens" : [ "Lucentis", "-", "Summary", "of", "Product", "Characteristics", "." ]
  }, {
    "sentence_tokens" : [ "Available", "from", ":", "http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf", "." ]
  }, {
    "sentence_tokens" : [ "Accessed", "01", "Feb", "2018", ")", ",", "following", "monthly", "intravitreal", "injections", "in", "AMD", "patients", ",", "serum", "concentrations", "of", "ranibizumab", "generally", "range", "between", "0.79", "and", "2.90", "ng/ml", "." ]
  }, {
    "sentence_tokens" : [ "Such", "concentrations", "are", "below", "the", "drug", "concentration", "necessary", "to", "inhibit", "the", "VEGF", "activity", "by", "50", "%", "(", "IC", "=", "11", "-", "27", "ng/ml", ")", "." ]
  }, {
    "sentence_tokens" : [ "Serum", "ranibizumab", "concentrations", "are", "predicted", "to", "be", "approximately", "90,000-fold", "lower", "than", "vitreal", "ranibizumab", "concentrations", "." ]
  }, {
    "sentence_tokens" : [ "Results", "from", "clinical", "trials", "documented", "no", "significant", "reduction", "in", "serum", "VEGF", "levels", "within", "the", "first", "1", "month", "of", "treatment", "(", "Zehetner", "et", "al", ".,", "2015", ")", ",", "but", "a", "significant", "decline", "in", "systemic", "VEGF", "levels", "was", "detected", "after", "1", "and", "2", "years", "(", "Enders", "et", "al", ".,", "2015", ")", "." ]
  }, {
    "sentence_tokens" : [ "The", "resulting", "systemic", "VEGF", "inhibition", "after", "intravitreal", "injections", "may", "lead", "to", "systemic", "effects", "(", "Gibson", "and", "Gibson", ",", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "Clinical", "trials", "on", "ranibizumab", "showed", "a", "high", "incidence", "of", "stroke", ",", "myocardial", "infarction", "and", "non", "ocular", "hemorrhage", "(", "Brown", "et", "al", ".,", "2006", ";", "Rosenfeld", "et", "al", ".,", "2006", ")", ",", "further", "confirmed", "by", "recent", "observational", "studies", "(", "Kemp", "et", "al", ".,", "2013", ";", "Pratt", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "Furthermore", ",", "a", "meta-analysis", "of", "randomized", "trials", "on", "ranibizumab", "for", "AMD", "treatment", "identified", "a", "stronger", "relationship", "of", "systemic", "vascular", "adverse", "events", "and", "intravitreal", "administration", "of", "VEGF", "inhibitors", "in", "case", "of", "more", "intensive", "treatment", "schedule", "(", "Ueta", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "Recent", "evidence", "suggested", "that", "the", "VEGF", "signal", "pathway", "may", "directly", "and", "indirectly", "improve", "DA", "neuron", "survival", "(", "Silverman", "et", "al", ".,", "1999", ";", "Pitzer", "et", "al", ".,", "2003", ";", "Yasuhara", "et", "al", ".,", "2004", ")", "." ]
  }, {
    "sentence_tokens" : [ "Functional", "polymorphisms", "of", "the", "VEGF", "gene", "expression", "have", "been", "associated", "with", "an", "increased", "risk", "of", "developing", "PD", "in", "the", "Chinese", "Ham", "population", "(", "Wu", "et", "al", ".,", "2016", ")", "." ]
  }, {
    "sentence_tokens" : [ "This", "hypothesis", "is", "consistent", "with", "a", "recent", "autopsy", "study", "in", "patients", "with", "dementia", "with", "Lewy", "body", ",", "in", "whom", "VEGF", "deficiency", "has", "been", "associated", "with", "a", "loss", "of", "microvessels", "and", "low", "occipital", "blood", "flow", "(", "Miners", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "On", "the", "other", "hand", ",", "VEGF", "is", "up-regulated", "by", "ischemic", "and", "inflammatory", "stimulation", ",", "which", "accompany", "neurodegeneration", "." ]
  }, {
    "sentence_tokens" : [ "These", "changes", "lead", "to", "edema", ",", "bleeding", ",", "and", "impair", "neural", "tissue", "perfusion", "." ]
  }, {
    "sentence_tokens" : [ "VEGF", "shows", "neuroprotective", "effects", ",", "due", "to", "apoptosis", "inhibition", ",", "stimulation", "of", "neurogenesis", ",", "and", "activation", "of", "antioxidants", "(", "Zachary", ",", "2005", ";", "Krum", "et", "al", ".,", "2008", ";", "Nowacka", "and", "Obuchowicz", ",", "2012", ";", "Quittet", "et", "al", ".,", "2015", ")", "." ]
  }, {
    "sentence_tokens" : [ "Specifically", ",", "ranibizumab", "binds", "to", "the", "VEGF-A", ",", "one", "of", "the", "five", "isoforms", "of", "the", "VEGF", "family", "and", "one", "of", "the", "strongest", "inducers", "of", "vascular", "permeability", "(", "Yla-Herttuala", "et", "al", ".,", "2007", ")", ",", "which", "showed", "neuroprotective", "effects", "in", "several", "in", "vitro", "and", "in", "vivo", "PD", "models", "(", "Silverman", "et", "al", ".,", "1999", ";", "Pitzer", "et", "al", ".,", "2003", ";", "Yasuhara", "et", "al", ".,", "2004", ";", "Tian", "et", "al", ".,", "2007", ";", "Yue", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "A", "recent", "study", "on", "the", "Italian", "ADR", "Spontaneous", "Reporting", "System", "showed", "3", "reports", "of", "\"", "extrapyramidal", "syndrome", "\"", "due", "to", "intravitreal", "bevacizumab", "and", "1", "to", "intravitreal", "aflibercept", "(", "Cutroneo", "et", "al", ".,", "2017", ")", "." ]
  }, {
    "sentence_tokens" : [ "Similarly", ",", "in", "the", "Food", "and", "Drug", "Administration", "'", "s", "Adverse", "Event", "Reporting", "System", ",", "three", "cases", "of", "neurodegenerative", "disorders", "have", "been", "reported", "following", "bevacizumab", "use", "(", "Shamloo", "et", "al", ".,", "2012", ")", "." ]
  }, {
    "sentence_tokens" : [ "On", "the", "other", "hand", ",", "the", "onset", "of", "such", "disorders", "may", "be", "due", "to", "vascular", "events", "and/or", "stroke", ",", "which", "are", "well", "known", "and", "listed", "risks", "of", "intravitreal", "therapy", "with", "anti-VEGF", "drugs", "in", "general", ",", "including", "ranibizumab", "." ]
  }, {
    "sentence_tokens" : [ "Finally", ",", "a", "meta-analysis", "of", "randomized", "trials", "on", "ranibizumab", "for", "AMD", "treatment", "identified", "a", "stronger", "relationship", "of", "systemic", "vascular", "adverse", "events", "and", "intravitreal", "administration", "of", "VEGF", "inhibitors", "in", "case", "of", "more", "intensive", "treatment", "schedule", "(", "Ueta", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "All", "the", "above", "described", "experimental", "and", "epidemiological", "evidence", "raise", "the", "hypothesis", "that", "persistent", "and", "intensive", "VEGF", "inhibition", "concurred", "to", "DA", "degeneration", "in", "our", "patient", "." ]
  }, {
    "sentence_tokens" : [ "AMD", "may", "be", "considered", "as", "a", "neurodegeneration", "of", "the", "retina", "(", "de", "Jong", ",", "2006", ")", ",", "thus", "potentially", "sharing", "with", "PD", "common", "biological", "pathways", ",", "such", "as", "oxidative", "stress", "and", "inflammation", "(", "Ding", "et", "al", ".,", "2009", ";", "Poewe", "et", "al", ".,", "2017", ")", "." ]
  }, {
    "sentence_tokens" : [ "Chung", "et", "al.", "(", "2014", ")", "investigated", "the", "risk", "of", "developing", "PD", "within", "3", "years", "after", "the", "AMD", "diagnosis", "in", "a", "retrospective", "cohort", ",", "population", "based", ",", "claims", "database", "study", "in", "Taiwan", "." ]
  }, {
    "sentence_tokens" : [ "Adjusting", "for", "several", "vascular", "risk", "factors", "(", "i.e", ".,", "coronary", "heart", "disease", ",", "hypertension", ",", "diabetes", ",", "and", "hyperlipidemia", ")", ",", "subjects", "with", "AMD", "had", "a", "significant", "higher", "risk", "of", "developing", "PD", "than", "AMD-free", "patients", "during", "follow-up", "." ]
  }, {
    "sentence_tokens" : [ "On", "the", "contrary", ",", "a", "case-control", "study", "found", "no", "statistically", "significant", "differences", "in", "the", "frequency", "of", "AMD", "between", "patients", "with", "idiopathic", "PD", "and", "healthy", "subjects", "(", "Nowacka", "et", "al", ".,", "2014", ")", "." ]
  }, {
    "sentence_tokens" : [ "Using", "claims", "databases", "from", "the", "United", "States", ",", "Brilliant", "et", "al.", "(", "2016", ")", "found", "that", "around", "70", "%", "of", "the", "levodopa", "users", "started", "the", "drug", "treatment", "after", "AMD", "diagnosis", "." ]
  }, {
    "sentence_tokens" : [ "Conclusion", "." ]
  }, {
    "sentence_tokens" : [ "In", "conclusion", ",", "our", "case", "report", "points", "out", "to", "VEGF", "inhibition", "as", "a", "possible", "additional", "risk", "factor", "of", "neurodegeneration", "of", "DA", "neurons", "in", "PD.According", "to", "the", "Naranjo", "causality", "assessment", "scale", "(", "Naranjo", "et", "al", ".,", "1981", ")", ",", "the", "causal", "relationship", "between", "use", "of", "ranibizumab", "and", "PD", "development", "was", "scored", "as", "\"", "possible", "\"", "." ]
  }, {
    "sentence_tokens" : [ "In", "particular", ",", "we", "hypothesize", "that", "long-term", "treatment", "with", "intravitreal", "ranibizumab", "led", "to", "a", "persistent", "inhibition", "of", "VEGF", "activity", "which", "played", "an", "important", "compensatory", "neuroprotective", "role", "in", "older", "patient", "with", "AMD", ",", "ultimately", "triggering", "PD", "." ]
  }, {
    "sentence_tokens" : [ "Ethics", "Statement", "." ]
  }, {
    "sentence_tokens" : [ "A", "signed", "statement", "of", "informed", "consent", "to", "publish", "the", "case", "description", "was", "obtained", "from", "the", "patient", "." ]
  }, {
    "sentence_tokens" : [ "Author", "Contributions", "." ]
  }, {
    "sentence_tokens" : [ "EM", ",", "CT", ",", "and", "FM", "collected", "the", "data", "and", "performed", "the", "investigation", "." ]
  }, {
    "sentence_tokens" : [ "GT", ",", "IM", ",", "PC", "wrote", "the", "manuscript", "in", "collaboration", "." ]
  }, {
    "sentence_tokens" : [ "ES", "and", "FM", "critically", "reviewed", "the", "manuscript", "for", "important", "intellectual", "content", "and", "suggested", "valuable", "comments", ",", "which", "improved", "the", "quality", "of", "the", "manuscript", "." ]
  }, {
    "sentence_tokens" : [ "Conflict", "of", "Interest", "Statement", "." ]
  }, {
    "sentence_tokens" : [ "FM", "declares", "she", "receives", "royalties", "from", "publication", "of", "the", "book", "\"", "Disorders", "of", "Movement", "\"", "(", "Springer", "2016", ")", "." ]
  }, {
    "sentence_tokens" : [ "She", "has", "been", "part", "of", "advisory", "boards", "of", "Medtronic", ",", "Merz", ",", "and", "UCB", "Pharma", "." ]
  }, {
    "sentence_tokens" : [ "She", "has", "received", "honoraria", "for", "speaking", "from", "UCB", "Pharma", ",", "Medtronic", ",", "Chiesi", ",", "Abbvie", ",", "Allergan", ",", "Merz", ",", "and", "Zambon", "." ]
  }, {
    "sentence_tokens" : [ "The", "other", "authors", "declare", "that", "the", "research", "was", "conducted", "in", "the", "absence", "of", "any", "commercial", "or", "financial", "relationships", "that", "could", "be", "construed", "as", "a", "potential", "conflict", "of", "interest", "." ]
  } ]
}